| Literature DB >> 33033344 |
Hocheol Lim1,2,3, Ayoung Baek3, Jongwan Kim1,3, Min Sung Kim1,3, Jiaxin Liu1, Ky-Youb Nam4, JeongHyeok Yoon4, Kyoung Tai No5,6,7.
Abstract
The prevalence of a novel β-coronavirus (SARS-CoV-2) was declared as a public health emergency of international concern on 30 January 2020 and a global pandemic on 11 March 2020 by WHO. The spike glycoprotein of SARS-CoV-2 is regarded as a key target for the development of vaccines and therapeutic antibodies. In order to develop anti-viral therapeutics for SARS-CoV-2, it is crucial to find amino acid pairs that strongly attract each other at the interface of the spike glycoprotein and the human angiotensin-converting enzyme 2 (hACE2) complex. In order to find hot spot residues, the strongly attracting amino acid pairs at the protein-protein interaction (PPI) interface, we introduce a reliable inter-residue interaction energy calculation method, FMO-DFTB3/D/PCM/3D-SPIEs. In addition to the SARS-CoV-2 spike glycoprotein/hACE2 complex, the hot spot residues of SARS-CoV-1 spike glycoprotein/hACE2 complex, SARS-CoV-1 spike glycoprotein/antibody complex, and HCoV-NL63 spike glycoprotein/hACE2 complex were obtained using the same FMO method. Following this, a 3D-SPIEs-based interaction map was constructed with hot spot residues for the hACE2/SARS-CoV-1 spike glycoprotein, hACE2/HCoV-NL63 spike glycoprotein, and hACE2/SARS-CoV-2 spike glycoprotein complexes. Finally, the three 3D-SPIEs-based interaction maps were combined and analyzed to find the consensus hot spots among the three complexes. As a result of the analysis, two hot spots were identified between hACE2 and the three spike proteins. In particular, E37, K353, G354, and D355 of the hACE2 receptor strongly interact with the spike proteins of coronaviruses. The 3D-SPIEs-based map would provide valuable information to develop anti-viral therapeutics that inhibit PPIs between the spike protein of SARS-CoV-2 and hACE2.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33033344 PMCID: PMC7544872 DOI: 10.1038/s41598-020-73820-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of 23 experimental structures analyzed in this work.
| Class | Complex | PDB ID | Total atom number | Calculation time (s) | Methods | Resolution (Å) |
|---|---|---|---|---|---|---|
| SARS-CoV-1 | hACE2/SARS-CoV-1 | 2AJF | 12,458 | 4739 | X-ray | 2.90 |
| hACE2/SARS-CoV-1 | 3D0G | 12,299 | 4369 | X-ray | 2.80 | |
| hACE2/SARS-CoV-1 | 3D0H | 12,304 | 4536 | X-ray | 3.10 | |
| hACE2/SARS-CoV-1 | 3D0I | 12,301 | 4432 | X-ray | 2.90 | |
| hACE2/SARS-CoV-1 | 3SCI | 12,256 | 4521 | X-ray | 2.90 | |
| hACE2/SARS-CoV-1 | 3SCJ | 12,257 | 4403 | X-ray | 3.00 | |
| hACE2/SARS-CoV-1 | 3SCK | 12,234 | 4444 | X-ray | 3.00 | |
| hACE2/SARS-CoV-1 | 3SCL | 12,236 | 4219 | X-ray | 3.00 | |
| hACE2/SARS-CoV-1 | 6ACG | 12,474 | 4634 | Cryo-EM | 5.40 | |
| hACE2/SARS-CoV-1 | 6ACJ | 12,474 | 4759 | Cryo-EM | 4.20 | |
| hACE2/SARS-CoV-1 | 6ACK | 12,473 | 4632 | Cryo-EM | 4.50 | |
| hACE2/SARS-CoV-1 | 6CS2 | 11,566 | 6697 | Cryo-EM | 4.40 | |
| SARS-CoV-1 antibody | SARS-CoV-1/80R | 2GHW | 6534 | 1228 | X-ray | 2.30 |
| SARS-CoV-1/m395 | 2DD8 | 6318 | 1802 | X-ray | 2.30 | |
| SARS-CoV-1/S230 state 1 | 6NB6 | 16,284 | 6927 | Cryo-EM | 4.20 | |
| SARS-CoV-1/S230 state 2 | 6NB7 | 6717 | 2276 | Cryo-EM | 4.50 | |
| SARS-CoV-1/F26G19 | 3BGF | 9284 | 2871 | X-ray | 3.00 | |
| HCoV-NL63 | hACE2/HCoV-NL63 | 3KBH | 11,243 | 3587 | X-ray | 3.31 |
| SARS-CoV-2 | hACE2/SARS-CoV-2 | 6M17 | 12,681 | 8551 | X-ray | 2.90 |
| hACE2/SARS-CoV-2 | 6VW1 | 12,896 | 8477 | X-ray | 2.68 | |
| hACE2/SARS-CoV-2 | 6LGZ | 13,593 | 13,018 | X-ray | 2.50 | |
| hACE2/SARS-CoV-2 | 6M0J | 12,863 | 8707 | X-ray | 2.45 | |
| SARS-CoV-2 antibody | SARS-CoV-2/B38 | 7BZ5 | 7611 | 4082 | X-ray | 1.84 |
Figure 1Interaction map among hACE2, SAS-CoV-1, HCoV-NL63, SARS-CoV-2, and SARS-CoV-1 antibodies. 3D-SPIEs-based interaction map consists of hACE2, RBD domains from SARS-CoV-1, HCoV-NL63, SARS-CoV-2, four SARS-CoV-1 antibodies, and one SARS-CoV-2 antibody. The interactions between hACE2 and RBD domain from SARS-CoV-2 are shown in the left-hand with black arrows. The interactions between one antibody (B38) and RBD domain from SARS-CoV-2 are shown in the left-hand with color bars. The interactions in hACE2 and RBD domain from SARS-CoV-1 are shown in the right-hand with black arrows. The interactions between hACE2 and HCoV-NL63 are colored in green in the middle. The interactions between four antibodies (80R, m395, S320, and F26G13) and RBD domain from SAR-CoV-1 are shown in the right-hand with color bars. the main hot spot region is colored in light red, and the secondary hot spot region in hACE2 is colored in light blue, and All interactions shown in this map have attractive PIE value more stable than − 3.0 kcal/mol, whose magnitudes are ignored.
Figure 2Two main hot spot regions between hACE2 and spike protein from SARS-CoV-2. The main first hot spot of hACE2 consists of D30 and K31, while the main second hot spot of hACE2 consists of E37, K353, G354, and D355. The hACE2 protein is represented by green ribbon and surface, while the RBD of spike protein from SARS-CoV-2 is represented by orange ribbon and surface (PDB ID: 6M0J). The key binding sites on surface from hACE2 are colored in dark green, while those from RBD-SARS-CoV-2 are colored in raspberry.